Linagliptin and Rifampicin: Drug Interaction Guide
Quick answer: This combination requires caution. Linagliptin and Rifampicin can be used together with adjustments and monitoring.
How Linagliptin interacts with Rifampicin
Rifampicin induces CYP3A4 and P-glycoprotein, reducing linagliptin AUC by approximately 40% and lowering DPP-4 inhibition.
What you should do
Monitor glycaemic control closely; consider switching to a non-CYP3A4 dependent oral agent such as metformin or an SGLT2 inhibitor during rifampicin therapy.
Key facts
Severity
Moderate — caution required
Mechanism
Rifampicin induces CYP3A4 and P-glycoprotein, reducing linagliptin AUC by approximately 40% and lowering DPP-4 inhibitio...
Action
Monitor glycaemic control closely; consider switching to a non-CYP3A4 dependent oral agent such as metformin or an SGLT2...
Frequently asked questions
Can I take Linagliptin and Rifampicin together?
With caution. Monitor glycaemic control closely; consider switching to a non-CYP3A4 dependent oral agent such as metformin or an SGLT2 inhibitor during rifampicin therapy.
What is the severity of this interaction?
The interaction between Linagliptin and Rifampicin is classified as Moderate — caution required. Rifampicin induces CYP3A4 and P-glycoprotein, reducing linagliptin AUC by approximately 40% and lowering DPP-4 inhibition.
What should I do if I'm prescribed both?
Monitor glycaemic control closely; consider switching to a non-CYP3A4 dependent oral agent such as metformin or an SGLT2 inhibitor during rifampicin therapy. Always consult your prescribing clinician — do not stop or change medications without medical guidance.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.